Patients who have used EzriCare or Delsam Pharma’s artificial tears and Delsam Pharma’s artificial ointment and develop signs or symptoms of an eye infection should seek immediate medical attention, the CDC said.
As of Monday, May 15, a total of 81 patients have been confirmed in 18 states.
The CDC notes that testing is not currently recommended for people who have used these products and are not showing any signs or symptoms of infection.
Adverse outcomes associated with clinical (non-surveillance) cultures and reported to public health included 14 patients with vision loss and 4 others with enucleation (surgical enucleation),
Eye infection symptoms may include:
- Yellow, green, or clear discharge from the eye
- eye pain or discomfort
- redness of the eyes or eyelids
- Sensation of something in the eye (foreign body sensation)
- increased sensitivity to light
- blurred vision
The 18 states where cases have been detected are:
- New York
- Connecticut
- New Jersey
- Pennsylvania
- Delaware
- Ohio
- california
- Colorado
- Florida
- Illinois
- North Carolina
- new mexico
- Nevada
- South Dakota
- Texas
- Utah
- washington
- the state of Wisconsin
To read the latest CDC advisory, click here.
Click here Follow Daily Voice Nassau and receive free news updates.
